MimiX Biotherapeutics

Switzerland
Othmarsingen, Aargau, Switzerland, CH-2075

Company profile

MimiX Biotherapeutics company profile

mimiX Biotherapeutics aims to deliver the next generation biofabrication technology, that will enable tissue manufacturing for therapeutic and diagnostic purposes. mimiX Biotherapeutics will make this vision a reality by providing an ultra-fast biomanufacturing technology capable of creating point-of-care patient-specific biological tissue equivalents for regenerative, personalized, and precision medicine.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2019-08-30

Headquarters

Postal code
CH-2075
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Last funding
Series A / 2023-10-16
Last equity funding
Series A
Investors
5
Lead investors
2
Founders
2
Articles
5

Founders and investors

Founders

Marc ThurnerTiziano Serra

Lead investors

Asia JetwayHermes Group

Investors

Asia JetwayDM CapitalHeraeusHermes GroupVenture Kick